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and simultaneously sparing the surrounding normal 
structures. Nevertheless, in order to decrease the growth of 
cancerous cells, a high dose of ionizing radiation is needed 
which would generally cause the side effects on healthy 
organs. The use of nanotechnology in cancer treatment offers 
some exciting possibilities including destroying cancer tumors 
with minimal damage to healthy tissues. Zinc Oxide 
nanoparticles (ZnO NPs) are wide band gap semiconductors 
and seem to have a good effect on increasing the absorbed 
dose of target volume especially when doped with a high Z 
element. The aim of this study is to evaluate the effect of 
ZnO NPs doped with Gadolinium on dose enhancement factor 
at different concentrations irradiating by 6MV photon beams.  
 
Material and Methods: In order to study the influence of this 
NP on dose enhancement, PRESAGE dosimeter was fabricated 
by the reported procedure and calibrated against ionization 
chamber, delivering certain levels of absorbed doses. Then 
various concentrations of ZnO NPs and also ZnO NPs doped 
with 5% Gd were incorporated in to PRESAGE composition and 
irradiated by 6 MV photon beams. By using a UV-Vis 
spectrophotometer, optical density changes and also dose 
enhancement factor (DEF) were determined. 
 
Results: Figure 1 shows the color changes of PRESAGE 
containing various concentrations of NPs. 
 
 
 
Fig1. PRESAGE filled cuvettes with and without NPs at dose of 
10Gy. 1) PRESAGE without NPs. 2) PRESAGE with 20µg/ml ZnO 
NPs doped with %5 Gd. 3) PRESAGE with 4000µg/ml ZnO NPs 
doped with %5 Gd. 4) PRESAGE with 4000µg/ml ZnO NPs. 
Table 1 shows DEF acquired by various concentrations of NPs. 
Table 1. DEF of various concentrations of NPs. 
 
 
 
Conclusion: The results of this study revealed that ZnO NPs 
doped with Gd are new proposing substances for enhancing 
the absorbed dose and increasing the therapeutic ratio even 
in high energy photon beams. Various reasons may cause the 
DEF for 6MV photon beams such as photoelectric effect for 
low energy photon beams in continues X-ray spectrum, 
attenuated photons or pair production effect. Using these 
NPs not only reduces the needed MU to deliver a certain 
amount of absorbed dose, but also can lead to great succeeds 
in reducing treatment time. The concentration of NPs has a 
direct relation with DEF. 
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Purpose or Objective: Photodynamic therapy (PDT) is an 
effective treatment modality for specific superficial tumors, 
which uses laser light to activate photosensitizers that have 
been selectively absorbed by tumor cells. However, the finite 
penetration depth of laser light has limited clinical 
applications of PDT. This work investigates the outcomes of 
using Cerenkov light emission from 45MV photon beams on a 
LA45 accelerator to activate photosensitizers for cancer 
therapy. We named this new treatment technique as Radio-
dynamic therapy (RDT). 
 
Material and Methods: Firstly, Monte Carlo simulations were 
utilized to simulate various energies of Cerenkov light and its 
spectroscopy in excited target areas and their efficiency for 
photosensitizer activation. Then, the inner excitation 
efficiency from Cerenkov light in RDT theoretically compared 
with the efficiency of exotic excitation from the external 
laser light in PDT. In addition, we also tested the difference 
of excitation efficiency between a patented catalyst 
coenzyme was added as a substrate and without the 
coenzyme. Next, utilize a specific probe of DMA (Singlet O2 
fluorescent probe-9, 10-dimethylanthracene) to detect 
singlet oxygen. Finally, we also compared our results with 
previous experimental results that reported in previous 
literatures.  
 
Results: Our Monte Carlo results showed that the Cerenkov 
light intensity induced at 45MV photon beams on a LA45 is 8 - 
10 times of the Cerenkov light intensity induced at 6MV beam 
on a conventional accelerator. In RDT, excitation efficiency 
to photosensitizers at 400-450nm peaked wavelength (Soret 
Band) equals 20 times of laser light at 630nm in PDT. The 
homogenous inner excitation in RDT is also about 20 times 
(continuous spectrum excitation and inner scattering) of the 
exotic excitation and exponential attenuation laser light in 
the target of using PDT. Furthermore, the patented catalyst 
coenzyme enhanced the excitation efficiency of 
photosensitizers by 3-6 times under different conditions. In 
clinical situation, the new technique RDT also showed 
favorable outcomes for early and late stage of specific 
cancers and it also good at metastatic cancers treatment. 
 
Conclusion: Our results indicated that the process of using 
the Cerenkov light emission from 45MV photon beams to 
excite photosensitizers has similar process and efficiency as 
conventional laser in PDT. Compared these advantages with 
conventional PDT, RDT may be developed into a potential 
treatment modality for cancer of various stages and other 
diseases.  
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